Article Versions Notes

Kumari S, Dandamudi M, Rani S, Behaeghel E, Behl G, Kent D, O’Reilly NJ, O’Donovan O, McLoughlin P, Fitzhenry L. Dexamethasone-Loaded Nanostructured Lipid Carriers for the Treatment of Dry Eye Disease. Pharmaceutics. 2021; 13(6):905. https://doi.org/10.3390/pharmaceutics13060905

Kumari, Sangeeta, Madhuri Dandamudi, Sweta Rani, Elke Behaeghel, Gautam Behl, David Kent, Niall J. O’Reilly, Orla O’Donovan, Peter McLoughlin, and Laurence Fitzhenry. 2021. "Dexamethasone-Loaded Nanostructured Lipid Carriers for the Treatment of Dry Eye Disease" Pharmaceutics 13, no. 6: 905. https://doi.org/10.3390/pharmaceutics13060905

Kumari, S., Dandamudi, M., Rani, S., Behaeghel, E., Behl, G., Kent, D., O’Reilly, N. J., O’Donovan, O., McLoughlin, P., & Fitzhenry, L. (2021). Dexamethasone-Loaded Nanostructured Lipid Carriers for the Treatment of Dry Eye Disease. Pharmaceutics, 13(6), 905. https://doi.org/10.3390/pharmaceutics13060905